DrugDashboards

Adrenalin

epinephrine · EPINEPHRINE 1 mg/mL · Injection · Intramuscular; Intravenous; Subcutaneous · Medical Purchasing Solutions, LLC

NDC 71872-7223-01 · 1 VIAL in 1 BAG / 1 mL in 1 VIAL · NDA · View full market →

The short version

25 companies supply this market — deep enough that no single failure threatens the supply. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 4× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for epinephrine (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 4× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $20.71 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
NDA204200
TE code
AP
Approval date
Dec 7, 2012
Patents / exclusivity
3 patents, 0 exclusivities
TypeNumber / codeExpires
patent9295657Mar 13, 2035
patent9119876Mar 13, 2035
patent12280024Mar 13, 2035

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of epinephrine (Injection)

LabelerStrengthFirst seenLast seen
Asclemed USA, Inc.EPINEPHRINE .3 mg/.3mLJul 15, 2026Sep 3, 2026
HF Acquisition Co LLC, DBA HealthFirstEPINEPHRINE 1 mg/mLJul 23, 2026Sep 3, 2026
HF Acquisition Co LLC, DBA HealthFirstEPINEPHRINE .3 mg/.3mLJul 15, 2026Sep 3, 2026
Par Health USA, LLCEPINEPHRINE 1 mg/mLJul 15, 2026Sep 3, 2026
Remedyrepack Inc.EPINEPHRINE .3 mg/.3mLJul 15, 2026Sep 3, 2026
A-S Medication SolutionsEPINEPHRINE .1 mg/mLJul 15, 2026Sep 2, 2026
A-S Medication SolutionsEPINEPHRINE .15 mg/.3mLJul 15, 2026Sep 2, 2026
Advanced Rx Pharmacy of Tennessee, LLCEPINEPHRINE .3 mg/.3mLJul 15, 2026Sep 2, 2026
American Regent, Inc.EPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals LLCEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals of New York LLCEPINEPHRINE .15 mg/.15mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals of New York LLCEPINEPHRINE .3 mg/.3mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals Private LimitedEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Asclemed Usa Inc.EPINEPHRINE .3 mg/.3mLJul 15, 2026Sep 2, 2026
Asclemed USA, Inc.EPINEPHRINE .15 mg/.15mLJul 15, 2026Sep 2, 2026
BPI Labs, LLCEPINEPHRINE 30 mg/30mLJul 15, 2026Sep 2, 2026
Bryant Ranch PrepackEPINEPHRINE .15 mg/.3mLJul 15, 2026Sep 2, 2026
Catalent Indiana, LLCEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Catalent Indiana, LLCEPINEPHRINE .5 mg/mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.EPINEPHRINE .1 mg/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstEPINEPHRINE .15 mg/.15mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstEPINEPHRINE .1 mg/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstEPINEPHRINE .15 mg/.3mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.EPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
International Medication Systems, LimitedEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
International Medication Systems, LimitedEPINEPHRINE .1 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCEPINEPHRINE .15 mg/.3mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCEPINEPHRINE .1 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCEPINEPHRINE .3 mg/.3mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLC.EPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Novo Nordisk Production Belgium SAEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
ProPharma DistributionEPINEPHRINE .1 mg/mLJul 15, 2026Sep 2, 2026
ProPharma DistributionEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Redpharm DrugEPINEPHRINE .3 mg/.3mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.EPINEPHRINE .1 mg/mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.EPINEPHRINE .15 mg/.15mLJul 15, 2026Sep 2, 2026
Sina Health IncEPINEPHRINE 1 mg/mLJul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.EPINEPHRINE .5 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Adrenalin — NDC 71872-7223-01," retrieved September 3, 2026, https://drugdashboards.com/drug/71872722301.

Free to cite with attribution — see how the data is put together.